Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HiCM-188 in severe chronic heart failure
NCT05223894Phase 2Recruiting
- Sponsor
- Help Therapeutics
- Start
- Jun 2022
- Primary completion
- Dec 2025
- Modality
- Patient-derived iPSCs, Allogeneic iPSCs
- Countries
- 1
01
Overview
A Phase 2 trial of HiCM-188 in chronic heart failure (CHF), sponsored by Help Therapeutics. Started Jun 2022; status: recruiting.
02
Drugs
HiCM-188
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on NCT05223894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05223894.